BNP Paribas Asset Management
TWST icon

BNP Paribas Asset Management’s Twist Bioscience TWST Stock Holding History

BNP Paribas Asset Management’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$91.9K Sell
893
-145
-14% -$9.44K ﹤0.01% 1576
2026
Q1 		$49.3K Buy
1,038
+258
+33% +$11.6K ﹤0.01% 1755
2025
Q4 		$25K Buy
780
+241
+45% +$7.52K ﹤0.01% 1882
2025
Q3 		$15K Buy
539
+16
+3% +$485 ﹤0.01% 1508
2025
Q2 		$19K Buy
+523
New +$18.1K ﹤0.01% 1524

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

BNP Paribas Asset Management's TWST Position: Q2 2026 in Review

BNP Paribas Asset Management reduced its Twist Bioscience (TWST) stake by 14% in Q2 2026, selling an estimated $9.44K and leaving 893 shares worth $91.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1576.

BNP Paribas Asset Management first reported a position in TWST in Q2 2025 and has held it in 5 quarters since. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • BNP Paribas Asset Management held 893 shares of Twist Bioscience worth $91.9K as of Q2 2026.
  • BNP Paribas Asset Management sold 145 Twist Bioscience shares in Q2 2026, an estimated $9.44K.
  • Twist Bioscience made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q2 2026, its #1576 holding.
  • BNP Paribas Asset Management first reported a position in Twist Bioscience in Q2 2025 and has held it in 5 quarters since.
  • 337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.